The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line

Minoru Takata1, Masamichi Ishiai, Hiroyuki Kitao

  • 1Laboratory of DNA Damage Signaling, Department of Late Effect Studies, Radiation Biology Center, Kyoto University, Yoshida-konoe, Sakyo-ku, Kyoto 606-8501, Japan. mtakata@house.rbc.kyoto-u.ac.jp

Mutation Research
|July 23, 2009
PubMed

Insights

The Fanconi anemia (FA) pathway is crucial for DNA repair. Studies using the DT40 chicken cell line have significantly advanced our understanding of this complex DNA damage signaling network.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The Fanconi anemia (FA) pathway is a critical DNA damage signaling network involving phosphorylation and ubiquitination.
  • Defects in the FA pathway or related DNA repair proteins lead to Fanconi anemia (FA), characterized by genomic instability, impaired DNA crosslink repair, and increased cancer risk.
  • The precise mechanisms of the FA pathway remain incompletely understood.

Purpose of the Study:

  • To review the current understanding of the Fanconi anemia (FA) pathway.
  • To highlight the contributions of studies utilizing the DT40 chicken B cell line in dissecting the FA pathway.
  • To discuss the role of the FA pathway in DNA damage response and disease pathogenesis.

Main Methods:

  • Utilizing the DT40 chicken B cell line as a model system for molecular dissection of the FA pathway.
  • Review of existing literature and research findings on the FA pathway.
  • Analysis of genetic and cellular studies focused on DNA repair mechanisms.

Main Results:

  • Studies using DT40 have provided key insights into the molecular components and functions of the FA pathway.
  • The DT40 model has facilitated the characterization of FA proteins and their roles in DNA crosslink repair.
  • Research in this model system has advanced the understanding of FA's link to genomic instability and cancer.

Conclusions:

  • The DT40 chicken B cell line has been instrumental in elucidating the complexities of the Fanconi anemia (FA) pathway.
  • Continued research using model systems like DT40 is essential for further understanding DNA damage signaling and developing therapeutic strategies for FA and associated cancers.
  • The FA pathway plays a vital role in maintaining genomic integrity and preventing tumorigenesis.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...